Nirvana Life Sciences Inc.
NIRVF
$0.08
-$0.01-8.07%
OTC PK
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 150.00% | 225.00% | -35.00% | 35.71% | -82.61% |
| Total Receivables | 2.19% | -1.47% | -11.68% | -11.03% | -0.72% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 6.38% | 5.00% | -15.29% | -6.00% | -61.48% |
|
|
|||||
| Total Current Assets | 6.38% | 5.00% | -15.29% | -6.00% | -61.48% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 6.38% | -89.54% | -15.29% | -6.00% | -91.09% |
|
|
|||||
| Total Accounts Payable | 54.66% | 9.56% | 6.24% | 39.86% | -32.23% |
| Total Accrued Expenses | -68.39% | -72.37% | -75.37% | 21.20% | 22.95% |
| Short-term Debt | 55.95% | 97.38% | 211.52% | 246.12% | 279.66% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 0.00% | -- |
| Total Other Current Liabilities | -- | -- | -- | 0.00% | -- |
| Total Current Liabilities | -48.36% | -53.30% | -55.07% | 29.49% | 19.42% |
|
|
|||||
| Total Current Liabilities | -48.36% | -53.30% | -55.07% | 29.49% | 19.42% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 55.95% | 97.38% | 211.52% | 246.12% | 279.66% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 249.45% | -76.24% | -100.00% | -- | -- |
| Total Liabilities | -42.57% | -56.09% | -55.15% | 29.49% | 21.78% |
|
|
|||||
| Common Stock & APIC | 21.34% | 13.09% | 13.67% | -0.54% | -7.56% |
| Retained Earnings | -10.82% | -2.96% | -3.39% | -3.69% | 1.48% |
| Treasury Stock & Other | 9.65% | -3.06% | 2.49% | 2.16% | -2.74% |
| Total Common Equity | 43.48% | 51.03% | 56.11% | -30.28% | -51.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 43.48% | 51.03% | 56.11% | -30.28% | -51.22% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 2.50% | 0.00% | 2.70% | 0.00% | -14.29% |
| Total Equity | 43.30% | 50.81% | 55.88% | -30.14% | -51.02% |
|
|
|||||